Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 5 (1) , 19-33
- https://doi.org/10.1016/s1368-7646(02)00002-x
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Bcl-xl antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabineInternational Journal of Cancer, 2001
- Cross-resistance in the 2′,2′-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugsEuropean Journal Of Cancer, 2000
- Postconfluent multilayered cell line cultures for selective screening of gemcitabineEuropean Journal Of Cancer, 1998
- Gemcitabine: Actions and InteractionsNucleosides and Nucleotides, 1997
- The influence of BIBW22BS, a dipyridamole derivative, on the antiproliferative effects of 5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenograftsEuropean Journal Of Cancer, 1995
- Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenograftsEuropean Journal Of Cancer, 1995
- Thymidylate synthase and drug resistanceEuropean Journal Of Cancer, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Molecular Cloning of Human Cytosolic Purine 5′-NucleotidaseBiochemical and Biophysical Research Communications, 1994
- Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenograftsEuropean Journal Of Cancer, 1993